The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3

Journal of Ethnopharmacology

Volumn 127, Issue 2, 2010, Pages 221-228

  Fengqin, Liu ^a   Yulin, Wang ^a   Xiaoxin, Zhu ^b   Youpeng, Jin ^a   Yan, Chen ^c   Qing qing, Wang ^a   Hong, Chang ^d   Jia, Song ^a   Lei, Huang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d QINGDAO UNIVERSITY   (China)

Author keywords

Antioxidant; Apoptosis; T lymphocytes subsets; Traditional Chinese Medicine; Viral myocarditis

Indexed keywords

ALDEHYDE DERIVATIVE; ASCORBIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; CHINESE DRUG; MALEIC DIALDEHYDE; QISHAOWUWEI; RIBAVIRIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASTRAGALUS PLANT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ULTRASTRUCTURE; CHINESE MEDICINE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOREGULATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PAEONIA; PAEONIA RUBRA; PHENOTYPE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SCHISANDRACEAE; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS MYOCARDITIS;

ANIMALS; CARDIOTONIC AGENTS; COXSACKIEVIRUS INFECTIONS; DRUGS, CHINESE HERBAL; ENTEROVIRUS B, HUMAN; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; PLANT EXTRACTS; PLANT ROOTS; RANDOM ALLOCATION;

COXSACKIEVIRUS; MURINAE; MUS;

EID: 73749087765     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.11.017     Document Type: Article

References (40)

1. Anandasabapathy S., and Frishman W.H. Innovative drug treatments for viral and autoimmune myocarditis. Journal of Clinical Pharmacology 38 (1998) 295-308
2. Badorff C., Lee G.H., Lamphear B.J., Martone M.E., Campbell K.P., Rhoads R.E., and Knowlton K.U. Enteroviral protease 2A cleaves dystroph: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nature Medicine 5 (1999) 320-326
3. Beck M.A. Antioxidants and viral infections: host immune response and viral pathogenicity. Journal of American College of Nutrition 20 (2001) 396S-397S (384S-388S; discussion)
4. Bergelson J.M., Mohanty J.G., Crowell R.L., St John N.F., Lublin D.M., and Finberg R.W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology 69 (1995) 1903-1906
5. Bishopric N.H., Andreka P., Slepak T., and Webster K.A. Molecular mechanisms of apoptosis in the cardiac myocyte. Current Opinion on Pharmacology 1 (2001) 141-150
6. Cardoso S.M., Pereira C., and Oliveira R. Mitochondrial function is differentially affected upon oxidative stress. Free Radical Biology & Medicine 26 (1999) 3-13
7. Chen P., and Zhou J. Abnormal metabolism of nitric oxide, oxidative stress and lipoperoxidative stress in patients with acute viral myocarditis. Chinese Medicine Journal (England) 114 (2001) 1132-1135
8. Chow L.H., Beisel K.W., and McManus B.M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Laboratory Investigation 66 (1992) 24-31
9. Deng W.L. Qing Re Liang Xue Yao. In: Shen Y.J. (Ed). Pharmacology of Chinese Materiae Medicine (2000), People's Medical Publishing House, Peking 283-288
10. Dhar-Mascareno M., Carcamo J.M., and Golde D.W. Hypoxia-reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radical Biology & Medicine 38 (2005) 1311-1322
11. Drory Y., Turetz Y., Hiss Y., Lev B., Fisman E.Z., Pines A., and Kramer M.R. Sudden unexpected death in persons less than 40 years of age. American Journal of Cardiology 68 (1991) 1388-1392
12. Ellis C.R., and Di Salvo T. Myocarditis: basic and clinical aspects. Cardiological Review 15 (2007) 170-177
13. Feldman A.M., and McNamara D. Myocarditis. New England Journal of Medicine 343 (2000) 1388-1398
14. Fujioka S., Kitaura Y., Ukimura A., Deguchi H., Kawamura K., Isomura T., Suma H., and Shimizu A. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. Journal of American College of Cardiology 36 (2000) 1920-1926
15. Hiraoka Y., Kishimoto C., Kurokawa M., Ochiai H., and Sasayama S. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice. Cardiovascular Research 26 (1992) 956-961
16. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross Jr. J., Muller W., and Chien K.R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 (1999) 189-198
17. Huang G.J. Shou Se Yao. In: Shen Y.J. (Ed). Pharmacology of Chinese Materiae Medicine (2000), People's Medical Publishing House, Peking 1009-1016
18. Ichikawa H., Wang L., and Konishi T. Prevention of cerebral oxidative injury by post-ischemic intravenous administration of Shengmai San. American Journal of Chinese Medicine 34 (2006) 591-600
19. Kawano H., Okada R., Kawano Y., Sueyoshi N., and Shirai T. Apoptosis in acute and chronic myocarditis. Japanese Heart Journal 35 (1994) 745-750
20. Ko K.M., and Chiu P.Y. Biochemical basis of the "Qi-invigorating" action of Schisandra berry (wu-wei-zi) in Chinese medicine. American Journal of Chinese Medicine 34 (2006) 171-176
21. Lenzo J.C., Fairweather D., Cull V., Shellam G.R., and James Lawson C.M. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. Journal of Molecular Cell Cardiology 34 (2002) 629-640
22. Li X.Y. Immunomodulating Chinese herbal medicines. Membrane Institute of Oswaldo Cruz 86 Suppl. 2 (1991) 159-164
23. Liu, J.P., Yang, M., Du, X.M., 2004. Herbal medicines for viral myocarditis. Cochrane Database Syst Rev, CD003711.
24. Magnani J.W., and Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
25. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovascular Research 60 (2003) 5-10
26. Meng D., Chen X.J., Bian Y.Y., Li P., Yang D., and Zhang J.N. Effect of astragalosides on intracellular calcium overload in cultured cardiac myocytes of neonatal rats. American Journal of Chinese Medicine 33 (2005) 11-20
27. Miller A.L. Botanical influences on cardiovascular disease. Alternative Medicine Review 3 (1998) 422-431
28. Opavsky M.A., Penninger J., Aitken K., Wen W.H., Dawood F., Mak T., and Liu P. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circulation Research 85 (1999) 551-558
29. Rezkalla S., Kloner R.A., Khatib G., Smith F.E., and Khatib R. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis. Journal of American College of Cardiology 12 (1988) 412-414
30. Saraste A., Arola A., Vuorinen T., Kyto V., Kallajoki M., Pulkki K., Voipio-Pulkki L.M., and Hyypia T. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovascular Pathology 12 (2003) 255-262
31. Sinclair S. Chinese herbs: a clinical review of Astragalus, Ligusticum, and Schizandrae. Alternative Medicine Review 3 (1998) 338-344
32. Siwik D.A., Tzortzis J.D., Pimental D.R., Chang D.L., Pagano P.J., Singh K., Sawyer D.B., and Colucci W.S. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circulation Research 85 (1999) 147-153
33. Sun R.Y., Ma Y.M., and Hong Z.Y. The dosage in designing pharmacological experiments. In: Xu S.Y., Bian R.L., and Chen X. (Eds). Methods for Pharmacology Experiments (2002), People's Medical Publishing House, Peking 202-203
34. Suzuki H., Matsumori A., Matoba Y., Kyu B.S., Tanaka A., Fujita J., and Sasayama S. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury. Journal of Clinical Investigation 91 (1993) 2727-2733
35. Wang N., Minatoguchi S., Arai M., Uno Y., Nishida Y., Hashimoto K., Xue-Hai C., Fukuda K., Akao S., Takemura G., and Fujiwara H. Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels. Circulation Journal 66 (2002) 763-768
36. Xie B., Zhou J.F., Lu Q., Li C.J., and Chen P. Oxidative stress in patients with acute coxsackievirus myocarditis. Biomedical and Environmental Science 15 (2002) 48-57
37. Xuejiang W., Ichikawa H., and Konishi T. Antioxidant potential of qizhu tang, a Chinese herbal medicine, and the effect on cerebral oxidative damage after ischemia reperfusion in rats. Biological & Pharmaceutical Bulletin 24 (2001) 558-563
38. Yip A.Y., Loo W.T., and Chow L.W. Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system - a Phase I minimization clinical trial. Biomedicine & Pharmacotherapy 61 (2007) 588-590
39. Zhang S.F., and Sun J.N. Bu Qi Yao. In: Shen Y.J. (Ed). Pharmacology of Chinese Materiae Medicine (2000), People's Medical Publishing House, Peking 880-884
40. Zhang Z.C., Li S.J., Yang Y.Z., Chen R.Z., Ge J.B., and Chen H.Z. Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis. Journal of Asian Natural Products Research 9 (2007) 145-151